Catalyst Wire Dossier Catalyst Wire Dossier

Equecabtagene autoleucel

equecabtagene autoleucel
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Equecabtagene autoleucel, covering 2025-03-30 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE) [NA]

See pricing